Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-21

FDA Approved: ZINPLAVA — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved ZINPLAVA (bezlotoxumab) from Merck Sharp & Dohme LLC under an original Biologics License Application. It is indicated to reduce the recurrence of C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinplava (bezlotoxumab)

Snippet

ORIG AP for ZINPLAVA (BEZLOTOXUMAB)